4//SEC Filing
Buell Jennifer 4
Accession 0001193125-26-004799
CIK 0001840229other
Filed
Jan 5, 7:00 PM ET
Accepted
Jan 6, 5:27 PM ET
Size
7.4 KB
Accession
0001193125-26-004799
Insider Transaction Report
Form 4
Buell Jennifer
Chief Executive Officer
Transactions
- Award
Common Stock
2026-01-02$11.12/sh+31,474$349,991→ 67,966 total - Award
Stock Option (Right to Buy)
2026-01-02+50,000→ 50,000 totalExercise: $11.12Exp: 2036-01-02→ Common Stock (50,000 underlying)
Footnotes (3)
- [F1]Reflects the executive's 2025 performance bonus award paid in MiNK Therapeutics, Inc. common stock. The stock issued is fully-vested on the date of issuance but is subject to a lockup restriction with 100% of the award released on February 2, 2026.
- [F2]$11.12 was the fair market value of MiNK Therapeutics, Inc. Common Stock on January 2, 2026, the stock issuance date.
- [F3]The option vests over a three-year period, with one-third of the options vesting on the one-year anniversary of the date of grant, with the remainder vesting in eight equal quarterly installments thereafter.
Documents
Issuer
MiNK Therapeutics, Inc.
CIK 0001840229
Entity typeother
Related Parties
1- filerCIK 0001711184
Filing Metadata
- Form type
- 4
- Filed
- Jan 5, 7:00 PM ET
- Accepted
- Jan 6, 5:27 PM ET
- Size
- 7.4 KB